查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1591985

免疫蛋白市場：按產品、應用和最終用戶分類 - 全球預測 2025-2030

Immunoprotein Market by Product (C3, C4, Free Light Chains), Application (Allergy Testing, Autoimmune Testing, Infectious Disease Testing), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年免疫蛋白市值為196.4億美元，預計2024年將達到215.4億美元，複合年成長率為10.16%，到2030年將達到386.7億美元。

免疫蛋白是指參與身體免疫反應的蛋白質，如免疫球蛋白、細胞激素、補體蛋白等。免疫蛋白的市場範圍涵蓋診斷、治療和研究應用。對它的需求正在增加，因為它在自體免疫疾病、過敏、感染疾病和癌症的診斷和治療中發揮著重要作用。在診斷學中，它們作為評估免疫系統功能的生物標記物，而在治療學中，源自免疫蛋白的單株抗體對於標靶治療至關重要。最終用途包括臨床實驗室、醫院、研究機構等。市場成長是由生物技術和基因組學的進步、慢性病的增加以及個人化醫療的需求所推動的。關鍵的成長機會在於開發利用免疫蛋白的新型治療方法和照護現場診斷工具。然而，高昂的研發成本、嚴格的法律規範以及可擴展性和可重複性問題等挑戰正在阻礙市場進步。測試方法標準化有限也可能影響市場的可靠性和可信度。為了抓住新的機遇，相關人員應該投資合作研究，以創新更安全、更有效的免疫蛋白解決方案，並加強利用巨量資料的生物資訊技術能力。向開拓的應用領域（例如神經退化性疾病）的多元化可能會提供開拓的成長潛力。此外，擴大新興市場進入可以刺激醫療基礎設施已開發地區的需求。創新可能集中在提高免疫測量的特異性和靈敏度，以及為資源匱乏的環境開發具有成本效益的攜帶式診斷試劑套件。市場競爭激烈，策略聯盟和收購突出，以加強產品平臺和市場佔有率。透過持續創新和策略調整來應對當前挑戰，公司可以最大限度地發揮免疫蛋白的潛力，並鞏固其在動態醫療保健環境中的地位。

主要市場統計
基準年[2023] 196.4億美元
預測年份 [2024] 215.4億美元
預測年份 [2030] 386.7億美元
複合年成長率（%） 10.16%

市場動態：揭示快速發展的免疫蛋白市場的關鍵市場洞察

供需的動態交互作用正在改變免疫蛋白市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 感染疾病和慢性病的發生率和盛行率增加
    • 世界上老年人數量不斷增加，診斷測試數量不斷增加
    • 偏好快速、準確的疾病診斷
  • 市場限制因素
    • 與常規微生物檢測相比，免疫蛋白檢測成本較高
  • 市場機會
    • 免疫診斷設備的技術進步
    • 為發現嚴重的治療方法而進行的有效研究和開發工作
  • 市場問題
    • 替代測試方法的可用性

波特五力：駕馭免疫蛋白市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點，避免潛在的挑戰，確保更強大的市場地位。

PESTLE分析：了解免疫蛋白市場的外部影響

外部宏觀環境因素在塑造免疫蛋白市場的表現動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析：了解免疫蛋白質市場的競爭格局

免疫蛋白市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：免疫蛋白市場供應商的績效評估

FPNV 定位矩陣是評估免疫蛋白市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製免疫蛋白市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，對免疫蛋白市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭格局中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1. 市場滲透率：詳細檢視當前市場環境，主要企業的廣泛資料，評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、主要產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 感染疾病和慢性病的發生率和盛行率增加
      • 隨著世界各地老年人數量的增加，診斷測試也在增加。
      • 優先考慮快速且準確的疾病診斷
    • 抑制因素
      • 免疫蛋白測試比常規微生物測試更昂貴
    • 機會
      • 免疫診斷設備的技術進步
      • 為發現嚴重的治療方法而進行的有效研究和開發工作
    • 任務
      • 替代測試方法的可用性
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章免疫蛋白市場：依產品

  • 介紹
  • C3
  • C4
  • 遊離輕鏈
  • 結合球蛋白
  • 免疫球蛋白A
  • 特異性IgE
  • 總免疫球蛋白E
  • IgG
  • IgM
  • 免疫固定法
  • 前白蛋白
  • 蛋白質電泳

第7章免疫蛋白質市場：依應用分類

  • 介紹
  • 過敏測試
  • 自體免疫測試
  • 傳染病檢查
  • 腫瘤學和內分泌學測試

第8章免疫蛋白市場：依最終用戶分類

  • 介紹
  • 醫院/診所

第9章美洲免疫蛋白市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太免疫蛋白市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲免疫蛋白市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Amgen Inc.
  • Celltrion Healthcare Co., Ltd.
  • Eli Lilly and Company
  • Entera Health, Inc.
  • Genentech, Inc. by F. Hoffmann-La Roche Ltd
  • Glaxosmithkline PLC
  • Merck KGaA
  • Neurobiologix, Inc.
  • Novartis AG
  • Pfizer Inc.
  • Progurt Inc.
  • Samsung Biologics by Samsung Electronics Co., Ltd.
  • SERO AS
  • TECHNOPATH Distribution Ltd. by Diploma PLC
  • Teva Pharmaceutical Industries Ltd.
Product Code: MRR-43127F7279D3

The Immunoprotein Market was valued at USD 19.64 billion in 2023, expected to reach USD 21.54 billion in 2024, and is projected to grow at a CAGR of 10.16%, to USD 38.67 billion by 2030.

Immunoprotein refers to proteins involved in the body's immune response, including immunoglobulins, cytokines, and complement proteins. The market scope for immunoproteins extends across diagnostics, therapeutics, and research applications. Necessity arises from their critical role in diagnosing and treating autoimmune diseases, allergies, infections, and cancer. In diagnostics, they serve as biomarkers to assess immune system function, while in therapeutics, monoclonal antibodies derived from immunoproteins are pivotal in targeted therapies. The end-use scope includes clinical laboratories, hospitals, and research institutions. Market growth is driven by advances in biotechnology and genomics, the increasing prevalence of chronic diseases, and demand for personalized medicine. Key growth opportunities lie in the development of novel therapies and point-of-care diagnostic tools leveraging immunoproteins. However, challenges such as high R&D costs, stringent regulatory frameworks, and issues of scalability and reproducibility hinder progress in the market. Limited standardization in testing methodologies can also affect the market's credibility and reliability. To seize emerging opportunities, stakeholders should invest in collaborative research to innovate safer, more effective immunoprotein-based solutions and enhance technological capabilities in bioinformatics to harness big data. Diversification into underexplored applications, such as neurodegenerative diseases, could offer untapped potential for growth. Additionally, expanding access to emerging markets can fuel demand where healthcare infrastructure is evolving. Innovation could focus on improving the specificity and sensitivity of immunoassays and developing cost-effective, portable diagnostic kits for lower-resource settings. The market nature is competitive, marked by strategic partnerships and acquisitions to bolster product pipelines and market share. By addressing current challenges through continuous innovation and strategic adaptation, businesses can leverage immunoproteins' full potential, solidifying their position in a dynamic healthcare landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 19.64 billion
Estimated Year [2024] USD 21.54 billion
Forecast Year [2030] USD 38.67 billion
CAGR (%) 10.16%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Immunoprotein Market

The Immunoprotein Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growth in incidence & prevalence of infectious and chronic diseases
    • Rising geriatric population across world and increase in diagnostic tests
    • Preferences for quick and accurate disease diagnosis
  • Market Restraints
    • Immunoprotein tests are costly as compared to routine microbiology assays
  • Market Opportunities
    • Technological advancements in immunodiagnostic instruments
    • Effective R&D efforts to discover therapeutics against critical disease
  • Market Challenges
    • Availability of alternative testing approaches

Porter's Five Forces: A Strategic Tool for Navigating the Immunoprotein Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Immunoprotein Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Immunoprotein Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Immunoprotein Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Immunoprotein Market

A detailed market share analysis in the Immunoprotein Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Immunoprotein Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Immunoprotein Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Immunoprotein Market

A strategic analysis of the Immunoprotein Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Immunoprotein Market, highlighting leading vendors and their innovative profiles. These include Amgen Inc., Celltrion Healthcare Co., Ltd., Eli Lilly and Company, Entera Health, Inc., Genentech, Inc. by F. Hoffmann-La Roche Ltd, Glaxosmithkline PLC, Merck KGaA, Neurobiologix, Inc., Novartis AG, Pfizer Inc., Progurt Inc., Samsung Biologics by Samsung Electronics Co., Ltd., SERO AS, TECHNOPATH Distribution Ltd. by Diploma PLC, and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Immunoprotein Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across C3, C4, Free Light Chains, Haptoglobin, IgA, IgE Specific, IgE Total, IgG, IgM, Immunofixation, Prealbumin, and Protein Electrophoresis.
  • Based on Application, market is studied across Allergy Testing, Autoimmune Testing, Infectious Disease Testing, and Oncology & Endocrinology Testing.
  • Based on End User, market is studied across Hospital & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growth in incidence & prevalence of infectious and chronic diseases
      • 5.1.1.2. Rising geriatric population across world and increase in diagnostic tests
      • 5.1.1.3. Preferences for quick and accurate disease diagnosis
    • 5.1.2. Restraints
      • 5.1.2.1. Immunoprotein tests are costly as compared to routine microbiology assays
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in immunodiagnostic instruments
      • 5.1.3.2. Effective R&D efforts to discover therapeutics against critical disease
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of alternative testing approaches
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Immunoprotein Market, by Product

  • 6.1. Introduction
  • 6.2. C3
  • 6.3. C4
  • 6.4. Free Light Chains
  • 6.5. Haptoglobin
  • 6.6. IgA
  • 6.7. IgE Specific
  • 6.8. IgE Total
  • 6.9. IgG
  • 6.10. IgM
  • 6.11. Immunofixation
  • 6.12. Prealbumin
  • 6.13. Protein Electrophoresis

7. Immunoprotein Market, by Application

  • 7.1. Introduction
  • 7.2. Allergy Testing
  • 7.3. Autoimmune Testing
  • 7.4. Infectious Disease Testing
  • 7.5. Oncology & Endocrinology Testing

8. Immunoprotein Market, by End User

  • 8.1. Introduction
  • 8.2. Hospital & Clinics

9. Americas Immunoprotein Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Immunoprotein Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Immunoprotein Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Amgen Inc.
  • 2. Celltrion Healthcare Co., Ltd.
  • 3. Eli Lilly and Company
  • 4. Entera Health, Inc.
  • 5. Genentech, Inc. by F. Hoffmann-La Roche Ltd
  • 6. Glaxosmithkline PLC
  • 7. Merck KGaA
  • 8. Neurobiologix, Inc.
  • 9. Novartis AG
  • 10. Pfizer Inc.
  • 11. Progurt Inc.
  • 12. Samsung Biologics by Samsung Electronics Co., Ltd.
  • 13. SERO AS
  • 14. TECHNOPATH Distribution Ltd. by Diploma PLC
  • 15. Teva Pharmaceutical Industries Ltd.

LIST OF FIGURES

  • FIGURE 1. IMMUNOPROTEIN MARKET RESEARCH PROCESS
  • FIGURE 2. IMMUNOPROTEIN MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL IMMUNOPROTEIN MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. IMMUNOPROTEIN MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. IMMUNOPROTEIN MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. IMMUNOPROTEIN MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL IMMUNOPROTEIN MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. IMMUNOPROTEIN MARKET DYNAMICS
  • TABLE 7. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY C3, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY C4, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY FREE LIGHT CHAINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY HAPTOGLOBIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY IGA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY IGE SPECIFIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY IGE TOTAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY IGG, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY IGM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY IMMUNOFIXATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY PREALBUMIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY PROTEIN ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY ALLERGY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY AUTOIMMUNE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY ONCOLOGY & ENDOCRINOLOGY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. INDIA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. INDIA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. INDONESIA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. INDONESIA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. INDONESIA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. JAPAN IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. JAPAN IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. JAPAN IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. MALAYSIA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. MALAYSIA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. MALAYSIA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. PHILIPPINES IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. PHILIPPINES IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. PHILIPPINES IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. SINGAPORE IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. SINGAPORE IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. SINGAPORE IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. SOUTH KOREA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. SOUTH KOREA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. SOUTH KOREA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. TAIWAN IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. TAIWAN IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. TAIWAN IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. THAILAND IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. THAILAND IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. THAILAND IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. VIETNAM IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. VIETNAM IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. VIETNAM IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 91. DENMARK IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. DENMARK IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. DENMARK IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. EGYPT IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. EGYPT IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. EGYPT IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. FINLAND IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. FINLAND IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. FINLAND IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. FRANCE IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. FRANCE IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. FRANCE IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. GERMANY IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. GERMANY IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. GERMANY IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. ISRAEL IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. ISRAEL IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. ISRAEL IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. ITALY IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. ITALY IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. ITALY IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. NETHERLANDS IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. NETHERLANDS IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. NETHERLANDS IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. NIGERIA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. NIGERIA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. NIGERIA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. NORWAY IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. NORWAY IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. NORWAY IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. POLAND IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. POLAND IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. POLAND IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. QATAR IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. QATAR IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. QATAR IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. RUSSIA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. RUSSIA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. RUSSIA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. SAUDI ARABIA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. SAUDI ARABIA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SAUDI ARABIA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH AFRICA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SOUTH AFRICA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SOUTH AFRICA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. SPAIN IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. SPAIN IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. SPAIN IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. SWEDEN IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. SWEDEN IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. SWEDEN IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. SWITZERLAND IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. SWITZERLAND IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. SWITZERLAND IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. TURKEY IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. TURKEY IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. TURKEY IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED ARAB EMIRATES IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED ARAB EMIRATES IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED ARAB EMIRATES IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. UNITED KINGDOM IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. UNITED KINGDOM IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. UNITED KINGDOM IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 154. IMMUNOPROTEIN MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 155. IMMUNOPROTEIN MARKET, FPNV POSITIONING MATRIX, 2023